TWI256951B - Thiazolyl amide derivatives - Google Patents
Thiazolyl amide derivativesInfo
- Publication number
- TWI256951B TWI256951B TW089127599A TW89127599A TWI256951B TW I256951 B TWI256951 B TW I256951B TW 089127599 A TW089127599 A TW 089127599A TW 89127599 A TW89127599 A TW 89127599A TW I256951 B TWI256951 B TW I256951B
- Authority
- TW
- Taiwan
- Prior art keywords
- amide derivatives
- thiazolyl amide
- thiazolyl
- medicaments
- derivatives
- Prior art date
Links
- -1 Thiazolyl amide Chemical class 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 2
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/54—Nitrogen and either oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
- C07F9/6539—Five-membered rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Ophthalmology & Optometry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19962532A DE19962532A1 (de) | 1999-12-23 | 1999-12-23 | Thiazolylamid-Derivate |
DE10039265A DE10039265A1 (de) | 2000-08-11 | 2000-08-11 | Thiazolylamid-Derivate |
Publications (1)
Publication Number | Publication Date |
---|---|
TWI256951B true TWI256951B (en) | 2006-06-21 |
Family
ID=26006669
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW089127599A TWI256951B (en) | 1999-12-23 | 2000-12-22 | Thiazolyl amide derivatives |
Country Status (27)
Country | Link |
---|---|
US (1) | US7105553B2 (zh) |
EP (1) | EP1244641B1 (zh) |
JP (1) | JP4726175B2 (zh) |
KR (1) | KR100768361B1 (zh) |
CN (1) | CN1235890C (zh) |
AR (1) | AR029210A1 (zh) |
AT (1) | ATE293104T1 (zh) |
AU (1) | AU784286B2 (zh) |
BR (1) | BR0017030B8 (zh) |
CA (1) | CA2396720C (zh) |
CO (1) | CO5261491A1 (zh) |
DE (1) | DE50010060D1 (zh) |
DK (1) | DK1244641T3 (zh) |
DO (1) | DOP2000000109A (zh) |
ES (1) | ES2240233T3 (zh) |
HK (1) | HK1057552A1 (zh) |
IL (2) | IL149897A0 (zh) |
MX (1) | MXPA02006243A (zh) |
MY (1) | MY134880A (zh) |
NZ (1) | NZ519701A (zh) |
PE (1) | PE20010964A1 (zh) |
PL (1) | PL208707B1 (zh) |
PT (1) | PT1244641E (zh) |
SV (1) | SV2002000249A (zh) |
TW (1) | TWI256951B (zh) |
UY (1) | UY26495A1 (zh) |
WO (1) | WO2001047904A1 (zh) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2000259734A1 (en) * | 2000-06-15 | 2001-12-24 | Gerald Kleymann | Method for identifying compounds with anti-herpes activity |
DE10129714A1 (de) * | 2001-06-22 | 2003-01-02 | Bayer Ag | Topische Anwendung von Thiazolylamiden |
DE10131128A1 (de) * | 2001-06-28 | 2003-01-16 | Bayer Ag | Sekundäre Sulfonamide |
AR037233A1 (es) * | 2001-09-07 | 2004-11-03 | Euro Celtique Sa | Piridinas aril sustituidas, composiciones farmaceuticas y el uso de dichos compuestos para la elaboracion de un medicamento |
AR036873A1 (es) | 2001-09-07 | 2004-10-13 | Euro Celtique Sa | Piridinas aril sustituidas a, composiciones farmaceuticas y el uso de las mismas para la preparacion de un medicamento |
EP2179744B1 (en) * | 2004-09-09 | 2010-12-01 | Novartis Vaccines and Diagnostics GmbH | Decreasing potential latrogenic risks associated with influenza vaccines |
DE102005014248A1 (de) * | 2005-03-30 | 2006-10-05 | Aicuris Gmbh & Co. Kg | Pharmazeutische Zubereitung von N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamid |
AU2006343359A1 (en) * | 2005-06-03 | 2007-11-15 | Xenon Pharmaceuticals Inc. | Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors |
US20070032488A1 (en) * | 2005-08-05 | 2007-02-08 | Genelabs Technologies, Inc. | 6-Membered aryl and heteroaryl derivatives for treating viruses |
CA2620878A1 (en) * | 2005-08-29 | 2007-04-05 | Gerard M. Housey | Theramutein modulators |
MX368352B (es) * | 2006-03-17 | 2019-09-30 | Univ Johns Hopkins | Derivados de n-hidroxilsulfonamida como nuevos donantes de nitroxilo fisiologicamente utiles. |
US20100051879A1 (en) * | 2006-11-22 | 2010-03-04 | The Regents od the Univesity of California | Functionalized Boron Nitride Nanotubes |
EP2573086A1 (en) | 2011-09-26 | 2013-03-27 | AiCuris GmbH & Co. KG | N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate |
EP2573085A1 (en) | 2011-09-26 | 2013-03-27 | AiCuris GmbH & Co. KG | N-[5-(aminosulfonyl)-4methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl] acetamide mesylate monohydrate having a specific particle size distribution range and a specific surface area range |
JP2016507546A (ja) * | 2013-02-12 | 2016-03-10 | アイクリス ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト | アルツハイマー病を治療する方法において使用するためのヘリカーゼ/プライマーゼ阻害剤 |
WO2016007538A1 (en) * | 2014-07-07 | 2016-01-14 | Prophylaxis, Llc | Viral prophylaxis treatment methods and pre-exposure prophylaxis kits |
MY198018A (en) * | 2016-04-06 | 2023-07-26 | Lnnovative Molecules Gmbh | Aminothiazole derivatives useful as antiviral agents |
DK3544976T3 (da) * | 2016-11-28 | 2021-05-10 | Aicuris Gmbh & Co Kg | N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamid-fri base hæmihydrat, fremgangsmåder til fremstilling og anvendelser deraf |
HUE054845T2 (hu) * | 2016-11-28 | 2021-10-28 | Aicuris Gmbh & Co Kg | Az N-[5-(amino-szulfonil)-4-metil-1,3-tiazol-2-il]-N-metil-2-[4-(2-piridinil)fenil]acetamid szabad bázis maleát sója, gyógyászati készítmények, elõállítási eljárások és Herpes vírusok kezelésére történõ alkalmazások |
WO2018095576A1 (en) | 2016-11-28 | 2018-05-31 | Aicuris Anti-Infective Cures Gmbh | Topical pharmaceutical formulation comprising n-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide |
EP3566749A4 (en) * | 2017-01-09 | 2020-09-23 | Medshine Discovery Inc. | THIAZOLE DERIVATIVE AND USES OF IT |
SI3692039T1 (sl) | 2017-10-05 | 2023-04-28 | Innovative Molecules Gmbh | Enantomeri substituiranih tiazolov kot protivirusne spojine |
AU2019297214B2 (en) * | 2018-07-06 | 2022-07-07 | Phaeno Therapeutics Co., Ltd. | Crystal forms of thiazole compound and application thereof |
EP3925595A1 (en) | 2020-06-17 | 2021-12-22 | AiCuris GmbH & Co. KG | Ophthalmic formulation comprising n-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl] acetamide hemihydrate |
KR20220160024A (ko) | 2020-03-26 | 2022-12-05 | 아이쿠리스 게엠베하 운트 코. 카게 | N-[5-(아미노술포닐)-4-메틸-1,3-티아졸-2-일]-n-메틸-2-[4-(2-피리디닐)페닐]아세트아미드 반수화물을 포함하는 안과용 제제 |
MX2023004955A (es) | 2020-10-29 | 2023-05-17 | Innovative Molecules Gmbh | Compuestos de aminotiazol deuterados como compuestos antiviricos. |
TW202337444A (zh) | 2022-01-17 | 2023-10-01 | 德商創新分子有限責任公司 | 解旋酶引子酶抑制劑的固體結晶形式及其製備方法 |
WO2024047506A1 (en) | 2022-08-29 | 2024-03-07 | Assembly Biosciences, Inc. | A novel crystalline form of pritelivir |
WO2024047507A1 (en) | 2022-08-29 | 2024-03-07 | Assembly Biosciences, Inc. | A novel crystalline form of pritelivir |
WO2024047508A1 (en) | 2022-08-29 | 2024-03-07 | Assembly Biosciences, Inc. | Pharmaceutical compositions for herpes virus |
WO2024049760A1 (en) | 2022-08-29 | 2024-03-07 | Assembly Biosciences, Inc. | Cyclic urea thiazolyl compounds for treatment of hsv |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3658830A (en) | 1970-01-16 | 1972-04-25 | Shell Oil Co | 5-(substituted mercapto sulfiny sulfonyl or sulfamoyl) |
CA984848A (en) | 1970-01-16 | 1976-03-02 | Kurt H. Pilgram | Herbicides |
US3847588A (en) | 1970-04-20 | 1974-11-12 | Shell Oil Co | Thiazoles herbicidal |
US3717651A (en) | 1970-04-20 | 1973-02-20 | Shell Oil Co | Thiazoles |
WO1997024343A1 (en) | 1995-12-29 | 1997-07-10 | Boehringer Ingelheim Pharmaceuticals, Inc. | Phenyl thiazole derivatives with anti herpes virus properties |
GB2311068A (en) | 1996-03-14 | 1997-09-17 | Merck & Co Inc | Helicase isolated from human cytomegalovirus (HCMV) |
GB2311069A (en) | 1996-03-14 | 1997-09-17 | Merck & Co Inc | Primase isolated from human cytomegalovirus (HCMV) |
US5705344A (en) | 1996-03-14 | 1998-01-06 | Tularik, Inc. | High-throughput screening assay for inhibitors of nucleic acid helicases |
CA2223032A1 (en) | 1997-02-21 | 1998-08-21 | Smithkline Beecham Corporation | Use of hsv-1 ul-15 and vp5 in identifying anti-viral agents |
DE19802437A1 (de) | 1998-01-23 | 1999-07-29 | Bayer Ag | Verwendung von substituierten Sulfonamiden als anitvirale Mittel und neue Stoffe |
AU3289299A (en) | 1998-02-19 | 1999-09-06 | Tularik Inc. | Antiviral agents |
AU743489B2 (en) | 1998-03-19 | 2002-01-24 | Pharmacia & Upjohn Company | 1,3,4-thiadiazoles useful for the treatment of CMV infections |
AU2914200A (en) | 1999-03-08 | 2000-09-28 | Bayer Aktiengesellschaft | Thiazolyl urea derivatives and their utilization as antiviral agents |
-
2000
- 2000-12-05 DO DO2000000109A patent/DOP2000000109A/es unknown
- 2000-12-12 KR KR1020027008155A patent/KR100768361B1/ko active IP Right Grant
- 2000-12-12 CA CA002396720A patent/CA2396720C/en not_active Expired - Lifetime
- 2000-12-12 WO PCT/EP2000/012564 patent/WO2001047904A1/de active IP Right Grant
- 2000-12-12 PT PT00991169T patent/PT1244641E/pt unknown
- 2000-12-12 DK DK00991169T patent/DK1244641T3/da active
- 2000-12-12 NZ NZ519701A patent/NZ519701A/en not_active IP Right Cessation
- 2000-12-12 AU AU31574/01A patent/AU784286B2/en not_active Expired
- 2000-12-12 PL PL356484A patent/PL208707B1/pl unknown
- 2000-12-12 AT AT00991169T patent/ATE293104T1/de active
- 2000-12-12 DE DE50010060T patent/DE50010060D1/de not_active Expired - Lifetime
- 2000-12-12 BR BRPI0017030A patent/BR0017030B8/pt not_active IP Right Cessation
- 2000-12-12 CN CNB008189676A patent/CN1235890C/zh not_active Expired - Lifetime
- 2000-12-12 US US10/168,197 patent/US7105553B2/en not_active Expired - Lifetime
- 2000-12-12 IL IL14989700A patent/IL149897A0/xx active IP Right Grant
- 2000-12-12 EP EP00991169A patent/EP1244641B1/de not_active Expired - Lifetime
- 2000-12-12 ES ES00991169T patent/ES2240233T3/es not_active Expired - Lifetime
- 2000-12-12 MX MXPA02006243A patent/MXPA02006243A/es active IP Right Grant
- 2000-12-12 JP JP2001549375A patent/JP4726175B2/ja not_active Expired - Lifetime
- 2000-12-20 AR ARP000106789A patent/AR029210A1/es active IP Right Grant
- 2000-12-20 UY UY26495A patent/UY26495A1/es not_active Application Discontinuation
- 2000-12-21 MY MYPI20006089A patent/MY134880A/en unknown
- 2000-12-22 TW TW089127599A patent/TWI256951B/zh not_active IP Right Cessation
- 2000-12-22 CO CO00097414A patent/CO5261491A1/es active IP Right Grant
- 2000-12-22 SV SV2000000249A patent/SV2002000249A/es active IP Right Grant
- 2000-12-22 PE PE2000001387A patent/PE20010964A1/es not_active IP Right Cessation
-
2002
- 2002-05-28 IL IL149897A patent/IL149897A/en unknown
-
2004
- 2004-01-19 HK HK04100401A patent/HK1057552A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI256951B (en) | Thiazolyl amide derivatives | |
ZA200201511B (en) | 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents. | |
MXPA02001497A (es) | Derivados de 3-(5)-ureido-pirazol, procedimiento para su preparacion y sus uso como agentes antitumorales. | |
HK1072597A1 (en) | Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same | |
HUP0203190A3 (en) | Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof | |
CA2400268A1 (en) | Pyrrolopyrimidinone derivatives, process of preparation and use | |
AU6231801A (en) | Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament | |
MY134892A (en) | Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use | |
HK1068336A1 (en) | Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents | |
CA2262566A1 (en) | Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect | |
HUP0203290A3 (en) | Indeno-, naphto-, and benzocyclohepta-dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments | |
SI1268522T1 (sl) | Novi antagonisti lhrh, njihova priprava in uporaba kot zdravila | |
MX9803672A (es) | Nuevos derivados de fenilamidina, procedimiento para su preparacion y su utilizacion como medicamentos. | |
PL346015A1 (en) | Methoximinophenylacetic acid amides | |
IL148161A0 (en) | Process for the preparation of 2-cyanopyridines | |
HUP0001249A3 (en) | Novel substituted dimeric compounds, process for their production and medicaments containing the same | |
HUP0202106A2 (en) | Thienopyranecarboxamide derivatives, process for the preparation thereof, pharmaceutical compositions containing them | |
AU2002242942A1 (en) | 3-0-'alfa-l-rhamnopyranosyl- (1-2) -alpha-l-rhamnopyranosyl- (1-4) -3beta-d-glucopyranosyl!-25 (s) -spirost an-3beta-ol, process for its isolation, and its use as immunomodulator | |
HUP0203593A3 (en) | Amycomycin, a process for its production and its use as a pharmaceutical | |
HU0001178D0 (en) | New propene-carbon acid-amidoxim derivatives, process for their production and medicaments containing the same | |
SI1194415T1 (en) | Novel piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same, and a process for their preparation | |
SI1230230T1 (en) | Indeno-dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments | |
AU2002230180A1 (en) | Novel peptides, derivatives thereof, process for producing the same, novel strains producing the same and antiviral agents containing the same as the active ingedient | |
SI1294682T1 (en) | Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament | |
HU9904486D0 (en) | Novel phtalazine derivatives, process for producing them and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK4A | Expiration of patent term of an invention patent |